Early Detection of Renal Abnormalities in Metabolically Healthy and Unhealthy Weight Excess"
Recruiting
Observational Study
Obesity
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 60
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- Istituto Auxologico Italiano · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Overweight and obesity are increasingly prevalent worldwide. Weight excess increases the risk of in developing the metabolic syndrome, which is composed by a set of cardiometabolic risk factors such as abdominal adiposity, dyslipidemia, high blood pressure and elevated fasting glucose levels. Obesity and the metabolic syndrome are known to be risk factors for the development of chronic kidney dise…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age between 18 and 60 years
* BMI at least 25 kg/m2
Exclusion Criteria:
* Pregnancy or breastfeeding
* Diabetes mellitus
* Renal disease
* Systemic autoimmune diseases with possible renal involvement
* Agonistic physical activity
* Heart failure
* Pharmacologcal treatment wi…
Contacts